SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-044086
Filing Date
2023-04-11
Accepted
2023-04-11 17:00:33
Documents
14
Period of Report
2023-04-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2312407d1_8k.htm   iXBRL 8-K 31135
2 EXHIBIT 99.1 tm2312407d1_ex99-1.htm EX-99.1 8834
  Complete submission text file 0001104659-23-044086.txt   274026

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA eucr-20230407.xsd EX-101.SCH 3839
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eucr-20230407_def.xml EX-101.DEF 27653
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE eucr-20230407_lab.xml EX-101.LAB 38597
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eucr-20230407_pre.xml EX-101.PRE 26271
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2312407d1_8k_htm.xml XML 6631
Mailing Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019
Business Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019 (212) 710-5220
Eucrates Biomedical Acquisition Corp. (Filer) CIK: 0001822929 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39650 | Film No.: 23813925
SIC: 6770 Blank Checks